Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$707K Buy
2,810
+227
+9% +$48.8K 0.31% 60
2026
Q1
$562K Buy
2,583
+80
+3% +$17.7K 0.29% 67
2025
Q4
$572K Buy
2,503
+103
+4% +$23.5K 0.31% 71
2025
Q3
$523K Sell
2,400
-209
-8% -$42.6K 0.31% 71
2025
Q2
$484K Buy
2,609
+36
+1% +$6.69K 0.34% 69
2025
Q1
$502K Buy
2,573
+46
+2% +$8.94K 0.44% 59
2024
Q4
$465K Buy
+2,527
New +$465K 0.4% 67

Other funds holding ABBV

Brucke Financial's ABBV Position: Q2 2026 in Review

Brucke Financial increased its AbbVie (ABBV) stake by 8.8% in Q2 2026, buying an estimated $48.8K and bringing the position to 2,810 shares worth $707K. The position accounts for 0.31% of the portfolio, ranked #60.

Brucke Financial first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,764 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brucke Financial held 2,810 shares of AbbVie worth $707K as of Q2 2026.
  • Brucke Financial bought 227 AbbVie shares in Q2 2026, an estimated $48.8K.
  • AbbVie made up 0.31% of Brucke Financial's portfolio in Q2 2026, its #60 holding.
  • Brucke Financial first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,764 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brucke Financial's 13F filing for Q2 2026, filed 21 Jul 2026.